Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone

• Published in: PloS one 2015-09, Vol.10 (9), p.e0138189-e0138189
• Main Authors: Xiong, Jinhu, Piemontese, Marilina, Onal, Melda, Campbell, Josh, Goellner, Joseph J, Dusevich, Vladimir, Bonewald, Lynda, Manolagas, Stavros C, O'Brien, Charles A
• Format: Article
• Language: English
• Subjects: Animals; Artificial chromosomes; Biocompatibility; Bone Density; Bone diseases; Bone growth; Bone mass; Bone Remodeling; Cancellous bone; Cell Division; Clonal deletion; Cre recombinase; Dentistry; Fluorescence; Gene deletion; Gene expression; Genetic engineering; Ligands; Lymphocytes; Metabolism; Mice; Mice, Transgenic; Mimicry; Osteoblasts; Osteoblasts - metabolism; Osteoclastogenesis; Osteoclasts - cytology; Osteocytes; Osteocytes - metabolism; Osteoporosis; Phenotypes; Proteins; RANK Ligand - genetics; RANK Ligand - metabolism; Recombinase; Recombination; Recombination, Genetic; Regulatory sequences; SOST protein; TRANCE protein; Transgenic animals; Transgenic mice
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0138189

The cytokine receptor activator of nuclear factor kappa B ligand (RANKL), encoded by the Tnfsf11 gene, is essential for osteoclastogenesis and previous studies have shown that deletion of the Tnfsf11 gene using a Dmp1-Cre transgene reduces osteoclast formation in cancellous bone by more than 70%. However, the Dmp1-Cre transgene used in those studies leads to recombination in osteocytes, osteoblasts, and lining cells making it unclear whether one or more of these cell types produce the RANKL required for osteoclast formation in cancellous bone. Because osteoblasts, osteocytes, and lining cells have distinct locations and functions, distinguishing which of these cell types are sources of RANKL is essential for understanding the orchestration of bone remodeling. To distinguish between these possibilities, we have now created transgenic mice expressing the Cre recombinase under the control of regulatory elements of the Sost gene, which is expressed in osteocytes but not osteoblasts or lining cells in murine bone. Activity of the Sost-Cre transgene in osteocytes, but not osteoblast or lining cells, was confirmed by crossing Sost-Cre transgenic mice with tdTomato and R26R Cre-reporter mice, which express tdTomato fluorescent protein or LacZ, respectively, only in cells expressing the Cre recombinase or their descendants. Deletion of the Tnfsf11 gene in Sost-Cre mice led to a threefold decrease in osteoclast number in cancellous bone and increased cancellous bone mass, mimicking the skeletal phenotype of mice in which the Tnfsf11 gene was deleted using the Dmp1-Cre transgene. These results demonstrate that osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling cancellous bone.